Announcement on Resolutions of the 2022 Annual General Meeting of Shareholders

release time:

2023-08-04 15:16

Stock code: 832316 Securities abbreviation: Tim Zheng Biotech Host brokerage: Shenwan Hongyuan underwriting sponsor

 

Jilin Tianzheng Biotechnology Co., Ltd
2022 Annual General Meeting Resolution Announcement

 

The Company and all members of the Board of Directors warrant that the content of the announcement is true, accurate and complete, and there are no false records, misleading statements or material omissions, and assume individual and joint legal responsibility for the authenticity, accuracy and completeness of its content.

 

1. Convening and attendance at meetings
(1) The convening of the meeting
1. The meeting will be held on May 2023, 5
2. Meeting location: conference room on the third floor of the company
3. Meeting mode: √ on-site voting□ online voting□ other ways of voting
4. Meeting Convener: Board of Directors
5. Meeting host: Chairman Cai Tiyuan
6.Convening SituationLegal Compliance Statement:The convening and holding of this general meeting of shareholders complies with the provisions of the Company Law, the Securities Law and other relevant laws, administrative regulations, departmental rules, normative documents and the Articles of Association.
(2) Attendance at the meeting
A total of 7 shareholders attended and authorized to attend this general meeting, with a total of 60,177,775 voting shares, accounting for 53.25% of the total number of voting shares of the company.
(3) The company's directors, supervisors and senior management personnel attending the general meeting of shareholders as observers
1. The company has 5 directors and 5 non-voting members;
2. The company has 3 supervisors and 3 non-voting members;
3. The secretary of the company's board of directors attends the meeting as an observer;
4. The company's senior management attends the meeting as observers.

 

2. Deliberation of motions
(2022) Deliberate and adopt the motion on the > of the <> Annual Report of the Board of Directors of the Company <
1. Content of the motion:
2022 Annual Report on the Work of the Board of Directors.
2. Voting results of motions:
60,177,775 Approved Shares of Common Stock, representing 100% of the total number of voting shares at this General Meeting; 0 opposing shares, representing 0% of the total number of voting shares at this general meeting; 0 abstained shares, representing 0% of the total number of voting shares at the General Meeting.
3. Recusal from voting
Not.
(2022) Deliberate and adopt the motion on the Company's <> Annual Report of the Board of Supervisors
1. Content of the proposal: "2022 Annual Report of the Board of Supervisors".
2. Voting results of the proposal: 60,177,775 ordinary shares were approved, accounting for 100% of the total number of voting shares at this general meeting; 0 opposing shares, representing 0% of the total number of voting shares at this general meeting; 0 abstained shares, representing 0% of the total number of voting shares at the General Meeting.
3. Recusal from voting
Not.
(2022) Deliberate and pass the motion on the company's <> financial final report
1. Content of the motion:
Financial Report 2022.
2. Voting results of motions:
60,177,775 ordinary shares, representing 100% of the total number of voting shares at this general meeting;
0 opposing shares, representing 0% of the total number of voting shares at this general meeting; The number of abstained shares is 0, accounting for this announcement number: 2023-013
0% of the total number of voting shares at the General Meeting.
3. Recusal from voting
Not.
(2023) Deliberate and adopt the "> on the Company's <<> Financial Budget Plan"
1. Content of the motion:
2023 Financial Budget Proposal.
2. Voting results of motions:
60,177,775 Approved Shares of Common Stock, representing 100% of the total number of voting shares at this General Meeting; 0 opposing shares, representing 0% of the total number of voting shares at this general meeting; 0 abstained shares, representing 0% of the total number of voting shares at the General Meeting.
3. Recusal from voting
Not.
(2022) Deliberate and adopt the motion on the "Summary > of the Company's <2022 Annual Report and <> Annual Report"
1. Content of the motion:
《2022 年年度报告及 2022 年年度报告摘要》。
2. Voting results of motions:
60,177,775 Approved Shares of Common Stock, representing 100% of the total number of voting shares at this General Meeting; 0 opposing shares, representing 0% of the total number of voting shares at this general meeting; 0 abstained shares, representing 0% of the total number of voting shares at the General Meeting.
3. Recusal from voting
Not.
(2022) Deliberate and adopt the "> on the Company's <> Profit Distribution Plan for the <"
1. Content of the motion:
In order to improve the soundness of finance, enhance the ability to resist risks, achieve sustainable, stable and healthy development of the company, and better safeguard the long-term interests of all shareholders, based on the actual situation of the company, the board of directors decided to:No profit distribution for 2022 will be made.
2. Voting results of motions:
60,177,775 Approved Shares of Common Stock, representing 100% of the total number of voting shares at this General Meeting; 0 opposing shares, representing 0% of the total number of voting shares at this general meeting; 0 abstained shares, representing 0% of the total number of voting shares at the General Meeting.
3. Recusal from voting
Not.
(2023) Deliberate and pass the motion on renewing the appointment of Grant Thornton Accounting Firm (Special General Partnership) as the Company's auditor for <>
1. Content of the motion:
The Company intends to continue to engage Grant Thornton (Special General Partnership) as the Company's auditor for 2023 for one year.
2. Voting results of motions:
60,177,775 Approved Shares of Common Stock, representing 100% of the total number of voting shares at this General Meeting; 0 opposing shares, representing 0% of the total number of voting shares at this general meeting; 0 abstained shares, representing 0% of the total number of voting shares at the General Meeting.
3. Recusal from voting
Not.
(8) Deliberate and pass the motion on Cai Tiyuan's lease of his own house to Jilin Tianzheng Biotechnology Co., Ltd
1. Content of the motion:
The company intends to lease Cai Tiyuan's house at No. 88, Building 3 [Building], Hongcheng International Garden Community, No. 1805 Southeast Lake Road, Nanguan District, Changchun City, with a transaction amount of 412,12 yuan per year.
2. Voting results of motions:
12,959,775 Approved Shares of Common Stock, representing 100% of the total number of voting shares at this General Meeting; 0 opposing shares, representing 0% of the total number of voting shares at this general meeting; 0 abstained shares, representing 0% of the total number of voting shares at the General Meeting.
3. Announcement No. 2023-013 on the situation of recusal from voting
Cai Tiyuan is the controlling shareholder and actual controller of the company, and Cai Tiyuan and the shareholder Cai Timing are brothers, so Cai Tiyuan and Cai Timing are related shareholders and recused themselves from voting.
III. Lawyers' witnesses
(1) Name of the law firm: Beijing Zhong Lun Law Firm
(2) Lawyers' names: Tan Zhongyi, Zhou Xingyin
(3) Concluding observations
The convocation and convening procedures of the company's shareholders' meeting comply with the provisions of the Articles of Association and relevant laws, administrative regulations, rules and normative documents, the qualifications of the convener of the meeting, the qualifications of the personnel attending the shareholders' meeting, and the qualificationsThe voting procedures and voting results of the meeting are legal and valid.
4. Catalog of documents for reference
"Resolution of the 2022 Annual General Meeting of Jilin Tianzheng Biotechnology Co., Ltd."
"Legal Opinion of Beijing Zhong Lun Law Firm on the 2022 Annual General Meeting of Jilin Tianzheng Biotechnology Co., Ltd."

 

Jilin Tianzheng Biotechnology Co., Ltd
board of directors
June 2023, 5